Measurement of visceral Fat: Should we include

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Hung, Chi Sheng ^a   Lee, Jen Kuang ^b   Yang, Chung Yi ^c   Hsieh, Hung Ren ^a   Ma, Wen Ya ^d   Lin, Mao Shin ^a   Liu, Pi Hua ^e   Shih, Shyang Rong ^a   Liou, Jyh Ming ^a   Chuang, Lee Ming ^a   Chen, Ming Fong ^a   Lin, Jou Wei ^a   Wei, Jung Nan ^f   Li, Hung Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CARDINAL TIEN HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALDOSTERONE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RENIN; TRIACYLGLYCEROL;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC INDEX; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PLASMA RENIN ACTIVITY; RETROPERITONEAL FAT; SUBCUTANEOUS FAT; ABDOMINAL FAT; AGED; ANATOMY AND HISTOLOGY; COMORBIDITY; HEALTH SURVEY; METABOLISM; MIDDLE AGED; MORPHOMETRICS; ORGAN SIZE; PATHOLOGY; RISK FACTOR;

ABDOMINAL FAT; ADIPOKINES; ADULT; AGED; BODY WEIGHTS AND MEASURES; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ORGAN SIZE; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84911861031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112355     Document Type: Article

References (24)

1. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
2. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, et al. (2005) Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112: 666-673.
3. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469-480.
4. Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S, et al. (2011) Assessing adiposity: a scientific statement from the American Heart Association. Circulation 124: 1996-2019.
5. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
6. Ross R, Aru J, Freeman J, Hudson R, Janssen I (2002) Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282: E657-663.
7. Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93: 359-404.
8. Cohen CA, Shea AA, Heffron CL, Schmelz EM, Roberts PC (2013) Intraabdominal fat depots represent distinct immunomodulatory microenvironments: a murine model. PLoS One 8: e66477.
9. Chapados N, Collin P, Imbeault P, Corriveau P, Lavoie JM (2008) Exercise training decreases in vitro stimulated lipolysis in a visceral (mesenteric) but not in the retroperitoneal fat depot of high-fat-fed rats. Br J Nutr 100: 518-525.
10. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39-48.
11. Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, et al. (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211: 283-286.
12. Borel AL, Boulet G, Nazare JA, Smith J, Almeras N, et al. (2013) Improved plasma FFA/insulin homeostasis is independently associated with improved glucose tolerance after a 1-year lifestyle intervention in viscerally obese men. Diabetes Care 36: 3254-3261.
13. Hung CS, Lee PC, Li HY, Ma WY, Lin MS, et al. (2011) Haemoglobin A1c is associated with carotid intima-media thickness in a Chinese population. Clin Endocrinol (Oxf) 75: 780-785.
14. Li HY, Lin MS, Shih SR, Hua CH, Liu YL, et al. (2011) The performance of risk scores and hemoglobin A1c to find undiagnosed diabetes with isolated postload hyperglycemia. Endocr J 58: 441-448.
15. Ma WY, Yang CY, Shih SR, Hsieh HJ, Hung CS, et al. (2013) Measurement of Waist Circumference: midabdominal or iliac crest? Diabetes Care 36: 1660-1666.
16. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, et al. (2001) The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 47: 1985-1992.
17. Tan CE, Ma S, Wai D, Chew SK, Tai ES (2004) Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27: 1182-1186.
18. Ersoz F, Erbil Y, Sari S, Salmaslioglu A, Issever H, et al. (2011) Predictive value of retroperitoneal fat area measurement for detecting metabolic syndrome in patients undergoing adrenalectomy. World J Surg 35: 986-994.
19. Yoshii H, Lam TK, Gupta N, Goh T, Haber CA, et al. (2006) Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux. Am J Physiol Endocrinol Metab 290: E1089-1097.
20. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, et al. (2005) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288: E454-461.
21. Rytka JM, Wueest S, Schoenle EJ, Konrad D (2011) The portal theory supported by venous drainage-selective fat transplantation. Diabetes 60: 56-63.
22. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, et al. (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58: 784-790.
23. Tchkonia T, Tchoukalova YD, Giorgadze N, Pirtskhalava T, Karagiannides I, et al. (2005) Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab 288: E267-277.
24. Betz MJ, Slawik M, Lidell ME, Osswald A, Heglind M, et al. (2013) Presence of brown adipocytes in retroperitoneal fat from patients with benign adrenal tumors: relationship with outdoor temperature. J Clin Endocrinol Metab 98: 4097-4104.